Lyell Immunopharma
Venture Capital
Lyell is a clinical-stage company advancing next-generation CAR T-cell product candidates for patients with cancer.
1+ investments
Biotech
- Website
- lyell.com
- Total Investment
- 1
- Last Investment
- Sep 2020
Overview
Lyell Immunopharma is a Venture Capital firm. It has made 1 investment in Biotech.
Investment History
Sign up to view investment history
Create a free account — 10 credits a month to unlock deal history, amounts, and round details.